secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2023-05-31T23:59:59+00:00
Accession:  0001816590-23-000072
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

COMPASS Pathways co-founder Ekaterina Malievskaia steps down as Chief Innovation Officer, remains on board
--------------------------------------------------------------------------------

- Dr. Malievskaia will step down as Chief Innovation Officer effective June 16, 2023, by mutual agreement.
- She will remain a non-executive director, Class I, with term expiring at 2024 annual meeting.
- Executive responsibilities will be assumed by the existing executive team.
- She co-founded COMPASS in 2017 and led the phase 2b trial of COMP360 psilocybin for treatment-resistant depression.
- Transitioning to non-executive director, she will receive annual cash retainer of $40,000 and equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000181659023000072/0001816590-23-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000181659023000072/cmps-20230530.htm
  HTML page:      https://secwatch.observer/filing/0001816590-23-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer